[{"Assets_0_Q1_USD":495469000.0,"CommonStockSharesOutstanding_0_Q1_shares":143886000.0,"EarningsPerShareBasic_1_Q1_USD":-0.19,"NetIncomeLoss_1_Q1_USD":-27461000.0,"StockholdersEquity_0_Q1_USD":265064000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":142656000.0,"Ticker":"HALO","CIK":"1159036","name":"HALOZYME THERAPEUTICS INC","OfficialName":"Halozyme Therapeutics Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5856719603.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180510"}]